Optomed has received a regulatory approval for a new product designed for the Chinese market
Optomed Plc Press Release 3 June 2020, 10.00, Helsinki Optomed has received a regulatory approval for a new product designed for the Chinese market Optomed has received a medical devices regulatory approval in China for a new camera product. This new product, Optomed Smartscope EY80, has a wider field-of-view, 80-degrees and it is designed for retinal screening of newborn babies and small children. Optomed believes that this is the first non-contact fundus camera approved in China for newborn imaging. This approval from the Chinese Food and Drug Administration (CFDA)